Eos Portfolio

Meet our inspiring founders. Companies are defined by people and their performance.

Led by: Rowan Armstrong
Bioliberty creates soft robotics technology to provide social care services to improve patient outcomes.
Led by: Simon Aspland
Led by: Arpan Desai
Led by: Lorna Ewart
Carcinotech is a MedTech company manufacturing 3D printed mini tumours developed from patient-specific cancer stem cells, primary cells and established cell lines.
Led by: Lee Cronin
Chemify is building the digital chemistry infrastructure to enable worldwide access to any desired compound instantly and on-demand
Led by: Jessica Birt
Led by: Clare Waring
Europes first cancer drug accelerator. Finding assets, creating spin-outs, commercialising cancer therapies.
Led by: Prof. Matthew J Baker
Offers a revolutionary spectroscopic liquid biopsy with artificial intelligence for the early detection of cancer and other diseases.
Led by: Jim Laird
Led by: Asel Sartbaeva
Led by: Gavin Munro
Formed in 2014 to offer Adjusta-Cone® as the world’s first fully adjustable differential pressure cone meter for natural gas.
Led by: Owain Millington
Led by: David Venables
Laverock Therapeutics is developing a unique gene silencing platform for the creation of programmable advanced therapies.
Led by: Nikki Palfrey
Led by: Giovanna Laudisio
Biodegradable, sustainable and cost competitive cellulose microparticles to replace plastic microbeads
Led by: Paul Cable
Led by: Gary Beale
An award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
Led by:
Novel Technologies has developed a technology where pure silver particles are incorporated into fibres as a antimicrobial coating for paints and textiles in a way that is ecologically sound and non-toxic to humans.
Led by: Richard Hammond
Penrhos Bio offers Remora technology, inspired by nature, that protects against bacteria, fungi, and algae, to provide self-cleaning surfaces.
Led by: Richard Kuo
Specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

Latest news

Wobble Genomics shares new data confirming ability to determine profiling of HER2 in tissue and blood
06 January 2026
Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis
11 December 2025

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.